SUMMIT
Last week Jonathan Norris, Managing Director at Silicon Valley Bank, wrote two very interesting articles on investing in life science companies. I’ve invested in the life science space with mediocre results, but I don’t know if that is because of my limited sample size or if I’m just not good at it 🙂 Even though both articles mostly talk about private equity, I think there are many takeaways for the public market place.
First Mover Advantage: The Case For Investing in Life Science
Questions surround the life science industry’s ability to provide substantial venture returns, the decline in fundraising, the difficulty of navigating the regulatory environment and establishing reimbursement. However, if we examine the underlying life science data and recent M&A activity, a different, decidedly positive perspective emerges.
Continued Rebound: Trends in Life Science M&A
Questions surround the life science industry’s ability to provide substantial venture returns, the decline in fundraising, the difficulty of navigating the regulatory environment and establishing reimbursement. However, if we examine the underlying life science data and recent M&A activity, a different, decidedly positive perspective emerges.
The MicroCapClub (mc2) is an exclusive micro cap forum focused on micro cap companies (sub $300m market cap). The MicroCapClub was created and founded by Ian Cassel as a way to share ideas and to learn from other seasoned like-minded micro cap investors. Our goal at MicroCapClub.com is quality membership and quality stock ideas. If you are an experienced micro cap investor, feel free to Apply today.